Covered recipient · General Payments record
FALLON R DAMICO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,141.11
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $373.59 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $305.16 | 6 |
| Lilly USA, LLC | $29.03 | 2 |
| Nevro Corp. | $25.28 | 1 |
| Sumitomo Pharma America, Inc. | $14.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Lilly USA, LLC | $15.96 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135659389 | CMS |
| Lilly USA, LLC | $13.07 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135678909 | CMS |
| Nevro Corp. | $25.28 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130786010 | CMS |
| Novo Nordisk Inc | $22.36 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100479685 | CMS |
| Novo Nordisk Inc | $16.12 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100437875 | CMS |
| Novo Nordisk Inc | $111.52 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100358934 | CMS |
| Novo Nordisk Inc | $125.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100353962 | CMS |
| Novo Nordisk Inc | $16.22 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100505501 | CMS |
| Novo Nordisk Inc | $13.94 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100442061 | CMS |
| Sumitomo Pharma America, Inc. | $14.12 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148954280 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.